In our non-randomized, pragmatic investigation, dexamethasone in severe COVID-19 affected circulating neutrophils, altered the IFNactive state, downregulated interferon-responsive genes and activated IL-1R2+ neutrophils. The gene discussed is IL1R2; the disease is COVID-19.